Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Breast 1

Conditions

Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

Exercise 27Metformin 20Surveys and Questionnaires 19Methods 14Educational Status 12Early Intervention, Educational 11Counseling 11Tirzepatide 9Standard of Care 9Nutrition Assessment 9Diet Therapy 9Resistance Training 8Radiotherapy 8Diet 8Interviews as Topic 7Liraglutide 6semaglutide 5Radiation 5Low-Level Light Therapy 5Exenatide 5Diet, Mediterranean 5Dexamethasone 5Cryotherapy 5Caloric Restriction 5Blood Specimen Collection 5Bariatric Surgery 5Vitamin D 4Therapeutics 4Sugars 4Specimen Handling 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × lorcaserin × Other × Clear all
NCT04205071 2021-01-19

Lorcaserin in Treating Chemotherapy-Induced Peripheral Neuropathy in Patients With Stage I-IV Gastrointestinal or Breast Cancer

Ohio State University Comprehensive Cancer Center

Phase 1 Withdrawn
BreastOther

Anatomic Stage I Breast Cancer AJCC v8

Data powered by HemOnc (CC BY 4.0) Colophon âš¡